Literature DB >> 7369301

Bilateral acute retinal necrosis.

F W Price, T F Schlaegel.   

Abstract

A 20-year-old woman lost all useful vision over a 2 1/2-month period as a result of a necrotizing and occlusive vasculitis of the retina. Treatment with prednisone, immunosuppressants, and aspirin was unsuccessful. No systemic manifestations of the disease were found and no cause was discovered. Kodachromes and fluorescein angiograms showed the progression in one eye from normal to near total retinal necrosis. The process began with a mild venous dilation and peripheral arteritis that progressed into an obliterative vasculitis with abrupt vessel dilation, hemorrhages, and retinal swelling. This was followed by necrosis and sloughing of the retina into the vitreous. Vitreous contraction and necrotic retina produced unrepairable retinal detachments.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7369301     DOI: 10.1016/0002-9394(80)90014-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Acute retinal necrosis syndrome.

Authors:  D S Gartry; D J Spalton; A Tilzey; P G Hykin
Journal:  Br J Ophthalmol       Date:  1991-05       Impact factor: 4.638

2.  Electrophysiological studies on Kirisawa type uveitis (acute retinal necrosis).

Authors:  S Yamamoto; E Adachi-Usami
Journal:  Doc Ophthalmol       Date:  1985-08-15       Impact factor: 2.379

3.  Surgical management of retinal detachment associated with the acute retinal necrosis syndrome.

Authors:  H R McDonald; H Lewis; A E Kreiger; Y Sidikaro; J Heckenlively
Journal:  Br J Ophthalmol       Date:  1991-08       Impact factor: 4.638

4.  Acute retinal necrosis.

Authors:  S Hayasaka; T Asano; K Yabata; A Ide
Journal:  Br J Ophthalmol       Date:  1983-07       Impact factor: 4.638

5.  Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS).

Authors:  A H Friedman; J Orellana; W R Freeman; M H Luntz; M B Starr; M L Tapper; I Spigland; H Roterdam; R Mesa Tejada; S Braunhut; D Mildvan; U Mathur
Journal:  Br J Ophthalmol       Date:  1983-06       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.